Ceftobiprole medocaril

Zeftera

500 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 2 Sept 2008

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Zeftera (previously Zevtera)European Union · Janssen-Cilag International NVSame brand
ZevteraUnited States · 667MG/VIAL · powder · IstxSame strength and form
ZevteraBrazil · United Medical LtdaSame substance
Zevtera 500 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 666.6 mg · polvo para concentrado para solución para perfusión · Advanz Pharma LimitedSame substance
MabelioItaly · Polvere per concentrato per soluzione per infusione · Advanz Pharma LimitedSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ceftobiprole medocaril

Zeftera

500 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 2 Sept 2008

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ZEVTERA 500 mg Powder for concentration for Solution for InfusionSaudi Arabia · Nipro Pharma Corporation Ise Plant

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ceftobiprole medocaril
Strength: 500 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 2 Sept 2008
Registration: DIN 02313103
Marketing authorisation holder: Janssen INC
ATC code: J01DI01
Group: Anti-infectives for systemic use
Supply: PRESCRIPTION